A Thermally Stable Recombinant Human Fibronectin Peptide-Fused Protein (rhFN3C) for Faster Aphthous Ulcer (AU) Healing
Approximately 59.4–100% of head and neck cancer patients receiving radiotherapy or radio chemotherapy suffer from aphthous ulcers (AUs), which seriously affect the subsequent treatment. At the same time, AUs are a common oral mucosal disease with a high incidence rate among the population, often acc...
Main Authors: | Xiang Cai, Jiawen Zhu, Xin Luo, Guoguo Jin, Yadong Huang, Lihua Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/11/1/38 |
Similar Items
-
Recurrent aphthous ulceration: a review of potential causes and novel treatments
by: Sami Kameel Saikaly, et al.
Published: (2018-08-01) -
Rebamipide: A novel agent in the treatment of recurrent aphthous ulcer and Behcet′s syndrome
by: Mohan H Kudur, et al.
Published: (2013-01-01) -
Oral epithelial dysplasia and aphthous ulceration in a patient with ulcerative colitis: a case report
by: Kai Sun, et al.
Published: (2023-03-01) -
Hyaluronic acid versus dexamethasone for the treatment of recurrent aphthous stomatitis in children: efficacy and safety analysis
by: Zheng Yang, et al.
Published: (2020-06-01) -
Recurrent Aphthous Stomatitis: Diagnosis and Management in Primary Care
by: Jillian Hudson
Published: (2014-11-01)